Dr. Anh Nguyen Appointed as Xeris' Chief Medical Officer Succeeding Ken Johnson PharmD, SVP, Global Development and Medical Affairs
Position
Chief Medical Officer
Company
Xeris Biopharma Holdings
ChicagoBiotechnologyHealthcareHealth CareBiopharmaDescription
Dr. Anh Nguyen has joined Xeris as Chief Medical Officer succeeding Ken Johnson PharmD, SVP, Global Development and Medical Affairs who will retire in April 1, 2025.
Quick answer
Dr. Anh Nguyen Appointed as Xeris' Chief Medical Officer Succeeding Ken Johnson PharmD, SVP, Global Development and Medical Affairs (February 25, 2025). Xeris Biopharma Holdings is based in Chicago, Illinois, United States.
- Who is the new Chief Medical Officer at Xeris Biopharma Holdings?
- Xeris Biopharma Holdings named Anh. Nguyen Chief Medical Officer, announced February 25, 2025.
- What did Xeris Biopharma Holdings announce on February 25, 2025?
- Dr. Anh Nguyen has joined Xeris as Chief Medical Officer succeeding Ken Johnson PharmD, SVP, Global Development and Medical Affairs who will retire in April 1, 2025.
- What does Xeris Biopharma Holdings do?
- Xeris Biopharma Holdings, Inc. is a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies.
- Where is Xeris Biopharma Holdings based?
- Xeris Biopharma Holdings is based in Chicago, Illinois, United States.
- Which similar companies made leadership changes around the same time?
- Crinetics Pharmaceuticals (February 26, 2025), Verastem Oncology (January 15, 2025), Climb Bio, Inc. (February 25, 2025) and Terns Pharmaceuticals (February 25, 2025) also announced leadership changes within 45 days of Xeris Biopharma Holdings.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
- Verastem Oncology Appoints Matthew E. Ros as Chief Operating Officer (January 15, 2025)
- Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer (February 25, 2025)
- Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer (February 25, 2025)
- Pfizer Hires Dr. Patrizia Cavazzoni as Chief Medical Officer to Replace Dr. Aida Habtezion (February 24, 2025)
- Bristol-Myers Squibb Appoints Cari Gallman as Executive Vice President and General Counsel, Succeeding Sandra Leung (February 21, 2025)
Who to call at Xeris Biopharma Holdings, and when
A new leader at Xeris Biopharma Holdings brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Xeris Biopharma Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Xeris Biopharma Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Xeris Biopharma Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Xeris Biopharma Holdings changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Xeris Biopharma Holdings changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.